341 related articles for article (PubMed ID: 28627982)
1. miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204.
Yang Y; Yu T; Jiang S; Zhang Y; Li M; Tang N; Ponnusamy M; Wang JX; Li PF
Expert Opin Ther Pat; 2017 Sep; 27(9):1021-1029. PubMed ID: 28627982
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
Hang P; Guo J; Sun C; Du Z
Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
[TBL] [Abstract][Full Text] [Related]
3. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-143/-145 in Cardiovascular Diseases.
Zhao W; Zhao SP; Zhao YH
Biomed Res Int; 2015; 2015():531740. PubMed ID: 26221598
[TBL] [Abstract][Full Text] [Related]
5. Small Molecules with Big Impacts on Cardiovascular Diseases.
Mirzadeh Azad F; Arabian M; Maleki M; Malakootian M
Biochem Genet; 2020 Jun; 58(3):359-383. PubMed ID: 31997044
[TBL] [Abstract][Full Text] [Related]
6. The role of miR-214 in cardiovascular diseases.
Zhao Y; Ponnusamy M; Zhang L; Zhang Y; Liu C; Yu W; Wang K; Li P
Eur J Pharmacol; 2017 Dec; 816():138-145. PubMed ID: 28842125
[TBL] [Abstract][Full Text] [Related]
7. The Role of microRNA in the Development, Diagnosis, and Treatment of Cardiovascular Disease: Recent Developments.
Wronska A
J Pharmacol Exp Ther; 2023 Jan; 384(1):123-132. PubMed ID: 35779862
[TBL] [Abstract][Full Text] [Related]
8. HDL and microRNA therapeutics in cardiovascular disease.
Michell DL; Vickers KC
Pharmacol Ther; 2016 Dec; 168():43-52. PubMed ID: 27595929
[TBL] [Abstract][Full Text] [Related]
9. Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases.
Felekkis K; Papaneophytou C
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952319
[TBL] [Abstract][Full Text] [Related]
10. microRNAs in cardiovascular disease - clinical application.
Schulte C; Karakas M; Zeller T
Clin Chem Lab Med; 2017 May; 55(5):687-704. PubMed ID: 27914211
[TBL] [Abstract][Full Text] [Related]
11. Circulating miRNAs as biomarkers in cardiovascular diseases.
Kaneto CM; Nascimento JS; Prado MSJG; Mendonça LSO
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2234-2243. PubMed ID: 30915771
[TBL] [Abstract][Full Text] [Related]
12. microRNAs in Cardiovascular Disease: Small Molecules but Big Roles.
Yan B; Wang H; Tan Y; Fu W
Curr Top Med Chem; 2019; 19(21):1918-1947. PubMed ID: 31393249
[TBL] [Abstract][Full Text] [Related]
13. A FGFR1 inhibitor patent review: progress since 2010.
Yu T; Yang Y; Liu Y; Zhang Y; Xu H; Li M; Ponnusamy M; Wang K; Wang JX; Li PF
Expert Opin Ther Pat; 2017 Apr; 27(4):439-454. PubMed ID: 27976968
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA208 family in cardiovascular diseases: therapeutic implication and potential biomarker.
Huang Y; Li J
J Physiol Biochem; 2015 Sep; 71(3):479-86. PubMed ID: 25840809
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in cardiovascular disease: an introduction for clinicians.
Romaine SP; Tomaszewski M; Condorelli G; Samani NJ
Heart; 2015 Jun; 101(12):921-8. PubMed ID: 25814653
[TBL] [Abstract][Full Text] [Related]
16. miRNAs as novel therapeutic targets and diagnostic biomarkers for Parkinson's disease: a patent evaluation of WO2014018650.
Hesse M; Arenz C
Expert Opin Ther Pat; 2014 Nov; 24(11):1271-6. PubMed ID: 25307171
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs as a Potential Biomarker in the Diagnosis of Cardiovascular Diseases.
Kramna D; Riedlova P; Jirik V
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512140
[TBL] [Abstract][Full Text] [Related]
18. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.
Bernardo BC; Ooi JY; Lin RC; McMullen JR
Future Med Chem; 2015; 7(13):1771-92. PubMed ID: 26399457
[TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.
Kwekkeboom RF; Lei Z; Doevendans PA; Musters RJ; Sluijter JP
Clin Sci (Lond); 2014 Sep; 127(6):351-65. PubMed ID: 24895056
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer.
Yang W; Ma J; Zhou W; Cao B; Zhou X; Yang Z; Zhang H; Zhao Q; Fan D; Hong L
Expert Opin Ther Targets; 2017 Nov; 21(11):1063-1075. PubMed ID: 28994330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]